Sarcoma News and Research

RSS
Presage Biosciences and AstraZeneca Partner to Advance Immuno-Oncology Research for Head and Neck Cancer

Presage Biosciences and AstraZeneca Partner to Advance Immuno-Oncology Research for Head and Neck Cancer

Specialized Diet Stimulates a Unique Form of Programmed Cell Death

Specialized Diet Stimulates a Unique Form of Programmed Cell Death

Protein that facilitates cancer-causing viruses dodge the immune system

Protein that facilitates cancer-causing viruses dodge the immune system

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Discovery of the gene responsible for rare childhood cancer

Discovery of the gene responsible for rare childhood cancer

Researchers demonstrate how tumors make immune cells less effective

Researchers demonstrate how tumors make immune cells less effective

Cancer biomarkers relying on methylation could forecast tumor type

Cancer biomarkers relying on methylation could forecast tumor type

Genomic changes in advanced tumors reveal interactions with treatment

Genomic changes in advanced tumors reveal interactions with treatment

Study reveals how the tumor suppressor gene plays a vital role in pediatric rhabdomyosarcoma

Study reveals how the tumor suppressor gene plays a vital role in pediatric rhabdomyosarcoma

Study analyzes the role of eIF4A3 protein in cancer cell growth

Study analyzes the role of eIF4A3 protein in cancer cell growth

New insights on how synovial sarcoma develops and spreads

New insights on how synovial sarcoma develops and spreads

A gene that impacts the development of bone cancer in children discovered

A gene that impacts the development of bone cancer in children discovered

Researchers identify drug that could overcome tumor resistance

Researchers identify drug that could overcome tumor resistance

Virus-mimicking drugs may overcome immunotherapy resistance in tumors

Virus-mimicking drugs may overcome immunotherapy resistance in tumors

UB biophysicist receives $2 million NIH grant to explore protein-RNA droplets

UB biophysicist receives $2 million NIH grant to explore protein-RNA droplets

Extrachromosomal DNA with potential to cause cancer drives poor patient outcomes

Extrachromosomal DNA with potential to cause cancer drives poor patient outcomes

Researchers identify key enzyme that drives the production of ribosomes

Researchers identify key enzyme that drives the production of ribosomes

New drug enables the immune system to attack ovarian cancer, TGen study shows

New drug enables the immune system to attack ovarian cancer, TGen study shows

A metabolic enzyme could be a potential drug target for B cell lymphomas

A metabolic enzyme could be a potential drug target for B cell lymphomas